Cogent Biosciences Inc (COGT)
8.425
-0.56
(-6.18%)
USD |
NASDAQ |
Jun 14, 16:00
8.435
+0.01
(+0.12%)
After-Hours: 20:00
Cogent Biosciences Price to Book Value: 4.602 for June 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 4.602 |
| June 13, 2024 | 4.905 |
| June 12, 2024 | 4.938 |
| June 11, 2024 | 4.818 |
| June 10, 2024 | 4.698 |
| June 07, 2024 | 4.007 |
| June 06, 2024 | 4.017 |
| June 05, 2024 | 4.260 |
| June 04, 2024 | 4.203 |
| June 03, 2024 | 4.003 |
| May 31, 2024 | 3.826 |
| May 30, 2024 | 3.482 |
| May 29, 2024 | 3.683 |
| May 28, 2024 | 4.017 |
| May 24, 2024 | 3.926 |
| May 23, 2024 | 3.578 |
| May 22, 2024 | 3.835 |
| May 21, 2024 | 3.783 |
| May 20, 2024 | 3.745 |
| May 17, 2024 | 3.554 |
| May 16, 2024 | 3.568 |
| May 15, 2024 | 3.687 |
| May 14, 2024 | 3.511 |
| May 13, 2024 | 3.511 |
| May 10, 2024 | 3.611 |
| Date | Value |
|---|---|
| May 09, 2024 | 3.783 |
| May 08, 2024 | 3.63 |
| May 07, 2024 | 3.706 |
| May 06, 2024 | 3.616 |
| May 03, 2024 | 3.597 |
| May 02, 2024 | 3.482 |
| May 01, 2024 | 3.31 |
| April 30, 2024 | 3.105 |
| April 29, 2024 | 3.205 |
| April 26, 2024 | 2.875 |
| April 25, 2024 | 2.871 |
| April 24, 2024 | 3.124 |
| April 23, 2024 | 3.324 |
| April 22, 2024 | 3.401 |
| April 19, 2024 | 3.205 |
| April 18, 2024 | 3.157 |
| April 17, 2024 | 3.119 |
| April 16, 2024 | 3.086 |
| April 15, 2024 | 3.105 |
| April 12, 2024 | 3.109 |
| April 11, 2024 | 3.128 |
| April 10, 2024 | 3.176 |
| April 09, 2024 | 3.339 |
| April 08, 2024 | 3.114 |
| April 05, 2024 | 3.205 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3011
Minimum
Mar 16 2020
6.800
Maximum
Jun 14 2023
2.944
Average
2.893
Median
Jul 22 2022
Price to Book Value Benchmarks
| Pfizer Inc | 1.690 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 18.62 |
| iBio Inc | 0.8879 |
| Theriva Biologics Inc | 0.1415 |
Price to Book Value Related Metrics
| PS Ratio | 31.15 |
| PEG Ratio | -0.0722 |
| Price | 8.425 |
| Earnings Yield | -29.44% |
| Market Cap | 921.22M |
| PEGY Ratio | -0.0722 |